
MaaT Pharma
Develops a series of microbiome-based drugs targeting mortality and comorbidities associated with blood cancer treatments.
Authorizing premium user...
Develops a series of microbiome-based drugs targeting mortality and comorbidities associated with blood cancer treatments.